<DOC>
	<DOCNO>NCT00860925</DOCNO>
	<brief_summary>Major non-cardiac surgery common major heart problem surgery represent large population health problem . Few treatment prevent heart problem around time surgery test . There encourage data suggest low-doses Acetyl-Salicylic Acid ( ASA ) Clonidine , two medication , give individually short period major surgery may prevent major heart problem .</brief_summary>
	<brief_title>PeriOperative ISchemic Evaluation-2 Pilot</brief_title>
	<detailed_description>The POISE-2 Pilot Trial provide essential remain feasibility data POISE-2 researcher require prior conduct large international study test effect ASA Clonidine prevent major vascular complication first 30 day surgery . The POISE-2 Pilot Trial factorial design randomize control trial compare ASA placebo clonidine placebo . Patients POISE-2 pilot trial randomly assign one four group : ASA Clonidine together , ASA Clonidine placebo , ASA placebo Clonidine , ASA placebo Clonidine placebo . Two four hour prior surgery , eligible patient give ASA study drug Clonidine study drug orally ( 162mg ASA placebo 0.2mg Clonidine placebo ) patch apply ( 0.2mg/day Clonidine placebo ) . The patch remain place 72 hour surgery . After surgery , patient ingest one tablet day ( 81mg ASA placebo ) 7 day patient take ASA chronically prior surgery 30 day chronically take ASA prior surgery . Troponin measurement collect 6 12 hour operation 1st , 2nd , 3rd day surgery . If blood test reveal elevation troponin measurement electrocardiogram ( ECG ) undertake immediately . Research personnel follow patient 30 day surgery .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Patients undergo noncardiac surgery fulfill follow criterion : age ≥ 45 year expect require least overnight hospital admission noncardiac surgery , fulfill 1 follow criterion : history coronary artery disease peripheral vascular disease stroke undergoing major vascular surgery ( i.e. , vascular surgery except arteriovenous shunt , vein strip procedure , carotid endarterectomy ) OR 3 9 risk criterion : 1. undergo major surgery [ i.e. , intraperitoneal , intrathoracic , orthopedic surgery ] 2. history congestive heart failure 3. transient ischemic attack 4. diabetes currently take oral hypoglycemic agent insulin 5. age = &gt; 70 year 6. hypertension 7. serum creatinine &gt; 175 µmol/L 8. history smoking within 2 year surgery , 9. undergoing emergent/urgent surgery Patients take ASA &lt; = 72 hour schedule surgery history ASA clonidine hypersensitivity allergy systolic blood pressure &lt; 105 mm Hg heart rate &lt; 55 beat per minute second third degree heart block without pacemaker patient active peptic ulcer disease Patient bare metal stent six week prior randomization Patient drug elute stent year prior randomization Patient currently take alpha2 agonist , alpha methyldopa , reserpine , clopidogrel , ticlopidine Patient undergo intracranial surgery , carotid endarterectomy , retinal surgery Surgeon unwilling patient participate participate perioperative clonidine/ASA trial Prior enrolment POISE2 pilot trial Unable obtain refusal consent prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Blinded</keyword>
	<keyword>Clonidine</keyword>
	<keyword>acetyl-salicylic acid ( ASA )</keyword>
	<keyword>Perioperative vascular complication</keyword>
	<keyword>Noncardiac surgery</keyword>
</DOC>